Corcept Therapeutics (CORT) Climbs 13.7% on Strong Clinical Trial Results
Corcept Therapeutics extended its winning streak to a third consecutive day on Thursday, jumping 13.74 percent to close at $41.30 apiece as investors cheered clinical results from its late-stage study...








